BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, Seo DW, Pantongrag-Brown L, Sangchan A, Pisespongsa P, Akaraviputh T, Reddy ND, Maydeo A, Itoi T, Pausawasdi N, Punamiya S, Attasaranya S, Devereaux B, Ramchandani M, Goh KL; Asia-Pacific Working Group on Hepatobiliary Cancers. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593-607. [PMID: 23350673 DOI: 10.1111/jgh.12128] [Cited by in Crossref: 135] [Cited by in F6Publishing: 113] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Buerlein RCD, Wang AY. Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma.Gastrointest Endosc Clin N Am. 2019;29:351-367. [PMID: 30846158 DOI: 10.1016/j.giec.2018.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Paik WH, Loganathan N, Hwang JH. Preoperative biliary drainage in hilar cholangiocarcinoma: When and how? World J Gastrointest Endosc 2014; 6(3): 68-73 [PMID: 24634710 DOI: 10.4253/wjge.v6.i3.68] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
3 Tang RSY, Sung JJY. Tricky yet clinically important issues after biliary self-expandable metal stent placement. J Gastroenterol Hepatol 2020;35:2027-8. [PMID: 33617041 DOI: 10.1111/jgh.15342] [Reference Citation Analysis]
4 Luo L, Yao Y, Liao H, Huang J, Liao M, Wang J, Yuan K, Zeng Y. Cumulative damage effect of jaundice may be an effective predictor of complications in patients undergoing radical resection of Bismuth type II or above hilar cholangiocarcinoma. Ann Transl Med 2021;9:861. [PMID: 34164495 DOI: 10.21037/atm-21-1860] [Reference Citation Analysis]
5 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
6 Kawakami H, Itoi T, Kuwatani M, Kawakubo K, Kubota Y, Sakamoto N. Technical tips and troubleshooting of endoscopic biliary drainage for unresectable malignant hilar biliary obstruction. J Hepatobiliary Pancreat Sci. 2015;22:E12-E21. [PMID: 25379788 DOI: 10.1002/jhbp.186] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
7 Tan Y, Zhu JY, Qiu BA, Xia NX, Wang JH. Percutaneous biliary stenting combined with radiotherapy as a treatment for unresectable hilar cholangiocarcinoma. Oncol Lett. 2015;10:2537-2542. [PMID: 26622885 DOI: 10.3892/ol.2015.3589] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
8 Nam HS, Kang DH. Current Status of Biliary Metal Stents. Clin Endosc 2016;49:124-30. [PMID: 26911896 DOI: 10.5946/ce.2016.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
9 Khoo S, Do NDT, Kongkam P. Efficacy and safety of EUS biliary drainage in malignant distal and hilar biliary obstruction: A comprehensive review of literature and algorithm. Endosc Ultrasound 2020;9:369-79. [PMID: 33318375 DOI: 10.4103/eus.eus_59_20] [Reference Citation Analysis]
10 Hu HJ, Wu ZR, Jin YW, Ma WJ, Yang Q, Wang JK, Liu F, Li FY. Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives. ANZ J Surg. 2019;89:476-480. [PMID: 30136376 DOI: 10.1111/ans.14765] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
11 Lee TH, Moon JH, Choi JH, Lee SH, Lee YN, Paik WH, Jang DK, Cho BW, Yang JK, Hwangbo Y, Park SH. Prospective comparison of endoscopic bilateral stent-in-stent vs stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture. Gastrointest Endosc. 2019;90:222-230. [PMID: 30905729 DOI: 10.1016/j.gie.2019.03.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 9.3] [Reference Citation Analysis]
12 Peng DZ, Lu J, Li B, Hu HJ, Ye XW, Xiong XZ, Cheng NS. A simple scoring system to predict early recurrence of Bismuth-Corlette type IV perihilar cholangiocarcinoma. Gastroenterol Rep (Oxf) 2019;7:345-53. [PMID: 31687154 DOI: 10.1093/gastro/goz012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Jirapinyo P, AlSamman MA, Thompson CC. Impact of infected stent removal on recurrent cholangitis with time-to-event analysis. Surg Endosc. 2019;33:4109-4115. [PMID: 30927127 DOI: 10.1007/s00464-019-06714-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Zhang JX, Ding Y, Yan HT, Zhou CG, Liu J, Liu S, Zu QQ, Shi HB. Skeletal-muscle index predicts survival after percutaneous transhepatic biliary drainage for obstructive jaundice due to perihilar cholangiocarcinoma. Surg Endosc 2020. [PMID: 33090316 DOI: 10.1007/s00464-020-08099-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Andrasina T, Rohan T, Panek J, Kovalcikova P, Kunovsky L, Ostrizkova L, Valek V. The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis - Randomized study. Eur J Radiol 2021;142:109830. [PMID: 34230002 DOI: 10.1016/j.ejrad.2021.109830] [Reference Citation Analysis]
16 Zhou HF, Lu J, Zhu HD, Guo JH, Huang M, Ji JS, Lv WF, Li YL, Xu H, Chen L, Zhu GY, Teng GJ. Early Warning Models to Estimate the 30-Day Mortality Risk After Stent Placement for Patients with Malignant Biliary Obstruction. Cardiovasc Intervent Radiol 2019;42:1751-9. [PMID: 31482338 DOI: 10.1007/s00270-019-02331-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Rohan T, Andrasina T, Juza T, Matkulcik P, Červinka D, Svobodova I, Novotná V, Bernard V, Valek V, Goldberg SN. Experimental model of occluded biliary metal stent recanalization using irreversible electroporation via a tubular catheter. Int J Hyperthermia 2021;38:393-401. [PMID: 33682581 DOI: 10.1080/02656736.2021.1875061] [Reference Citation Analysis]
18 Schiavon LL, Ejima FH, Menezes MR, Bittencourt PL, Moreira AM, Farias AQ, Chagas AL, Assis AM, Mattos ÂZ, Salomão BC, Terra C, Martins FPB, Carnevale FC, Rezende GFDM, Paulo GA, Pereira GHS, Leal Filho JMDM, Meneses J, Costa LSND, Carneiro MV, Álvares-DA-Silva MR, Soares MVA, Pereira OI, Ximenes RO, Durante RFS, Ferreira VA, Lima VM; Members of the Pannel of the 1st Joint Meeting of the SBH, SOBED and SOBRICE. RECOMMENDATIONS FOR INVASIVE PROCEDURES IN PATIENTS WITH DISEASES OF THE LIVER AND BILIARY TRACT: REPORT OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN SOCIETY OF DIGESTIVE ENDOSCOPY (SOBED) AND BRAZILIAN SOCIETY OF INTERVENTIONAL RADIOLOGY AND ENDOVASCULAR SURGERY (SOBRICE). Arq Gastroenterol 2019;56:213-31. [PMID: 31460590 DOI: 10.1590/S0004-2803.201900000-42] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kitamura K, Yamamiya A, Ishii Y, Mitsui Y, Nomoto T, Yoshida H. Side-by-side partially covered self-expandable metal stent placement for malignant hilar biliary obstruction. Endosc Int Open. 2017;5:E1211-E1217. [PMID: 29202005 DOI: 10.1055/s-0043-117955] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
20 Yu H, Miao L. Biliary stenting for cholangiocarcinoma: An update. Shijie Huaren Xiaohua Zazhi 2014; 22(5): 648-653 [DOI: 10.11569/wcjd.v22.i5.648] [Reference Citation Analysis]
21 Fu YF, Xu YS, Shi YB, Zong RL, Cao C. Percutaneous metal stenting for malignant hilar biliary obstruction: a systematic review and meta-analysis of unilateral vs bilateral stenting. Abdom Radiol (NY). 2021;46:749-756. [PMID: 32671439 DOI: 10.1007/s00261-020-02643-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Peng YC, Lin CL, Hsu WY, Chow WK, Lee SW, Yeh HZ, Chang CS, Kao CH. Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study. Medicine (Baltimore). 2015;94:e926. [PMID: 26061315 DOI: 10.1097/md.0000000000000926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
23 Inoue T, Ibusuki M, Kitano R, Kobayashi Y, Ohashi T, Nakade Y, Sumida Y, Ito K, Nakao H, Yoneda M. Combined side‐by‐side and stent‐in‐stent method for triple metal stenting in patients with malignant hilar biliary obstruction. Digestive Endoscopy 2019;31:698-705. [DOI: 10.1111/den.13448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
24 Choi JH, Lee SH, You MS, Shin BS, Choi YH, Kang J, Jang S, Paik WH, Ryu JK, Kim YT. Step-wise endoscopic approach to palliative bilateral biliary drainage for unresectable advanced malignant hilar obstruction. Sci Rep 2019;9:13207. [PMID: 31519930 DOI: 10.1038/s41598-019-48384-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Peng D, Lu J, Hu H, Li B, Ye X, Cheng N. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma. J Gastrointest Surg. 2020;24:330-340. [PMID: 30671792 DOI: 10.1007/s11605-018-04086-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
26 Lee TH, Kim TH, Moon JH, Lee SH, Choi HJ, Hwangbo Y, Hyun JJ, Choi JH, Jeong S, Kim JH, Park DH, Han JH, Park SH. Bilateral vs unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017;86:817-827. [PMID: 28479493 DOI: 10.1016/j.gie.2017.04.037] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 13.8] [Reference Citation Analysis]
27 Yang F, Wang XM, Xia FF, Han XQ. Endoscopic metal stenting for malignant hilar biliary obstruction: an update meta-analysis of unilateral versus bilateral stenting. Wideochir Inne Tech Maloinwazyjne 2021;16:472-81. [PMID: 34691298 DOI: 10.5114/wiitm.2021.104196] [Reference Citation Analysis]
28 Roque J, Ho SH, Reddy N, Goh KL. Endoscopic ablation therapy for biliopancreatic malignancies. Clin Endosc. 2015;48:15-19. [PMID: 25674521 DOI: 10.5946/ce.2015.48.1.15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
29 Coelen RJ, Huiskens J, Olthof PB, Roos E, Wiggers JK, Schoorlemmer A, van Delden OM, Klümpen HJ, Rauws EA, van Gulik TM. Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma. United European Gastroenterol J 2017;5:519-26. [PMID: 28588883 DOI: 10.1177/2050640616673517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Wang ZB, Zhang HY, Lu JB. Expression and Effects of Long Non-Coding RNA, LINC01124, in Non-Small Cell Lung Cancer. Onco Targets Ther 2019;12:11729-36. [PMID: 32099381 DOI: 10.2147/OTT.S214049] [Reference Citation Analysis]
31 Lu J, Guo JH, Zhu HD, Zhu GY, Wang Y, Zhang Q, Chen L, Wang C, Pan TF, Teng GJ. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma. ESMO Open. 2017;2:e000242. [PMID: 29018577 DOI: 10.1136/esmoopen-2017-000242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
32 Hu HJ, Jin YW, Zhou RX, Ma WJ, Yang Q, Wang JK, Liu F, Cheng NS, Li FY. Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma. J Gastrointest Surg 2019;23:510-7. [PMID: 30076591 DOI: 10.1007/s11605-018-3892-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Lee TH. Technical tips and issues of biliary stenting, focusing on malignant hilar obstruction. Clin Endosc. 2013;46:260-266. [PMID: 23767037 DOI: 10.5946/ce.2013.46.3.260] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
34 Liu J, Xue P, Deng J. Therapeutic effect of photodynamic therapy for nonresectable cholangiocarcinoma: Protocol for a meta-analysis and systematic review. Medicine (Baltimore) 2018;97:e9863. [PMID: 29465572 DOI: 10.1097/MD.0000000000009863] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Pereira SP, Goodchild G, Webster GJM. The endoscopist and malignant and non-malignant biliary obstruction. Biochim Biophys Acta Mol Basis Dis 2018;1864:1478-83. [PMID: 28931489 DOI: 10.1016/j.bbadis.2017.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Jang SI, Hwang JH, Lee KH, Yu JS, Kim HW, Yoon CJ, Lee YS, Paik KH, Lee SH, Lee DK. Percutaneous biliary approach as a successful rescue procedure after failed endoscopic therapy for drainage in advanced hilar tumors. J Gastroenterol Hepatol 2017;32:932-8. [PMID: 27665310 DOI: 10.1111/jgh.13602] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
37 Poruk KE, Pawlik TM, Weiss MJ. Perioperative Management of Hilar Cholangiocarcinoma. J Gastrointest Surg 2015;19:1889-99. [PMID: 26022776 DOI: 10.1007/s11605-015-2854-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
38 Nanashima A, Hiyoshi M, Imamura N, Hamada T, Nishida T, Kawakami H, Ban T, Kubota Y, Nakashima K, Yano K, Wada T, Takeno S, Kai M. Two cases of bile duct carcinoma patients who underwent the photodynamic therapy using talaporfin sodium (Laserphyrin®). Clin J Gastroenterol 2020;13:102-9. [PMID: 31222455 DOI: 10.1007/s12328-019-01006-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Wang CC, Yang TW, Sung WW, Tsai MC. Current Endoscopic Management of Malignant Biliary Stricture. Medicina (Kaunas). 2020;56. [PMID: 32151099 DOI: 10.3390/medicina56030114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Li M, Bai M, Qi X, Li K, Yin Z, Wang J, Wu W, Zhen L, He C, Fan D. Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center. Cardiovasc Intervent Radiol. 2015;38:709-721. [PMID: 25338831 DOI: 10.1007/s00270-014-0992-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
41 Lee TH, Moon JH, Park S. Biliary stenting for hilar malignant biliary obstruction. Digestive Endoscopy 2019;32:275-86. [DOI: 10.1111/den.13549] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
42 Zheng YW, Miao XY, Xiong L, Chen B, Kong FH, Zhou JJ, Liu ZT, Wen Y, Zhang ZJ, Zou H. Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT. Front Pharmacol 2021;12:723488. [PMID: 34483935 DOI: 10.3389/fphar.2021.723488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Almuhaidb A, Olson D, Aadam AA. Advancements in Endoscopic Biliary Interventions by Gastroenterology. Semin Intervent Radiol 2021;38:280-90. [PMID: 34393338 DOI: 10.1055/s-0041-1731266] [Reference Citation Analysis]
44 Hong JB, Kang DH, Nam HS, Choi CW, Kim HW, Park SB, Kim SJ, Choi WH. Endoscopic reintervention for stent malfunction after stent-in-stent deployment for malignant hilar obstruction. Medicine (Baltimore) 2017;96:e8867. [PMID: 29310368 DOI: 10.1097/MD.0000000000008867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
45 Tanisaka Y, Ryozawa S, Mizuide M, Fujita A, Ogawa T, Tashima T, Noguchi T, Suzuki M, Katsuda H, Araki R. Usefulness of self-expandable metal stents for malignant biliary obstruction using a short-type single-balloon enteroscope in patients with surgically altered anatomy. J Hepatobiliary Pancreat Sci 2021;28:272-9. [PMID: 33421277 DOI: 10.1002/jhbp.889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
46 Wang JK, Hu HJ, Shrestha A, Ma WJ, Yang Q, Liu F, Cheng NS, Li FY. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma? Oncotarget 2017;8:45335-44. [PMID: 28484084 DOI: 10.18632/oncotarget.17336] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
47 Jiang H, Zhang H, Hu X, Li W. Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137/PXN axis in non-small cell lung cancer. Int J Biol Macromol 2018;111:623-31. [PMID: 29337100 DOI: 10.1016/j.ijbiomac.2018.01.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
48 Chang G, Xia FF, Li HF, Niu S, Xu YS. Unilateral vs bilateral stent insertion for malignant hilar biliary obstruction. Abdom Radiol (NY). 2017;42:2745-2751. [PMID: 28477177 DOI: 10.1007/s00261-017-1174-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
49 Hu HJ, Mao H, Tan YQ, Shrestha A, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY. Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma. Springerplus. 2016;5:551. [PMID: 27190750 DOI: 10.1186/s40064-016-2181-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
50 Feng JW, Yang XH, Wu BQ, Jiang Y, Qu Z. Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma. Gastroenterol Hepatol 2019;42:271-9. [PMID: 30583874 DOI: 10.1016/j.gastrohep.2018.11.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Wang L, Lin N, Xin F, Zeng Y, Liu J. Comparison of long-term efficacy between endoscopic and percutaneous biliary drainage for resectable extrahepatic cholangiocarcinoma with biliary obstruction: A systematic review and meta-analysis. Saudi J Gastroenterol 2019;25:81-8. [PMID: 30720001 DOI: 10.4103/sjg.SJG_429_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
52 Maruki Y, Hijioka S, Wu SYS, Ohba A, Nagashio Y, Kondo S, Morizane C, Ueno H, Okusaka T, Saito Y. Novel endoscopic technique for trisegment drainage in patients with unresectable hilar malignant biliary strictures (with video). Gastrointest Endosc 2020;92:763-9. [PMID: 32169434 DOI: 10.1016/j.gie.2020.03.003] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Mao X, Wen F, Liang H, Sun W, Lu Z. A preliminary single-center investigation of percutaneous biliary stenting in malignant hilar biliary obstruction: what impacts the clinical success and the long-term outcomes? Support Care Cancer 2021. [PMID: 33990879 DOI: 10.1007/s00520-021-06271-0] [Reference Citation Analysis]
54 Zhao Z, Song J, Fan X, Fang S, Chen M, Chen W, Wu F, Zheng L, Tu J, Ji J. Primary Clinical Application of Y-Shaped Jogged Stent Implantation in Patients with Malignant Hilar Biliary Obstruction. J Gastrointest Surg 2019;23:745-50. [DOI: 10.1007/s11605-019-04131-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Saxena P, Kumbhari V, Zein ME, Khashab MA. Preoperative biliary drainage. Dig Endosc. 2015;27:265-277. [PMID: 25293587 DOI: 10.1111/den.12394] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
56 Boulay BR, Birg A. Malignant biliary obstruction: From palliation to treatment. World J Gastrointest Oncol 2016; 8(6): 498-508 [PMID: 27326319 DOI: 10.4251/wjgo.v8.i6.498] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
57 Shiryaev A, Musaev G, Levkin V, Reshetov I, Loshchenov M, Alekseeva P, Volkov V, Linkov K, Makarov V, Shchekoturov I, Borodkin A, Loschenov V. Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice. Photodiagnosis and Photodynamic Therapy 2019;26:218-23. [DOI: 10.1016/j.pdpdt.2019.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
58 Li Z, Jiang X, Xiao H, Chen S, Zhu W, Lu H, Cao L, Xue P, Li H, Zhang D. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma. Surg Endosc 2021;35:5655-64. [PMID: 33104917 DOI: 10.1007/s00464-020-08095-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
59 Kongkam P, Tasneem AA, Rerknimitr R. Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in malignant hilar biliary obstruction. Dig Endosc. 2019;31 Suppl 1:50-54. [PMID: 30994233 DOI: 10.1111/den.13371] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
60 Bokemeyer A, Matern P, Bettenworth D, Cordes F, Nowacki TM, Heinzow H, Kabar I, Schmidt H, Ullerich H, Lenze F. Endoscopic Radiofrequency Ablation Prolongs Survival of Patients with Unresectable Hilar Cholangiocellular Carcinoma - A Case-Control Study.Sci Rep. 2019;9:13685. [PMID: 31548703 DOI: 10.1038/s41598-019-50132-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
61 Lee TH, Jang SI, Moon JH, Lee YN, Yang JK, Park JS, Jeong S, Lee DH, Heo NH, Park SH, Lee DK. Endoscopic revision efficacy after clinically successful bilateral metal stenting for advanced malignant hilar obstruction. J Gastroenterol Hepatol 2020;35:2248-55. [PMID: 32472962 DOI: 10.1111/jgh.15123] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Lee TH, Moon JH, Park SH. [A Recent Update on Endoscopic Drainage of Advanced Malignant Hilar Obstruction]. Korean J Gastroenterol 2021;78:94-104. [PMID: 34446632 DOI: 10.4166/kjg.2021.111] [Reference Citation Analysis]
63 Tabibian JH, Baron TH. Endoscopic Management of Biliary Obstruction. In: Carey EJ, Lindor KD, editors. Cholestatic Liver Disease. New York: Springer; 2014. pp. 229-52. [DOI: 10.1007/978-1-4939-1013-7_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Fu Y, Zhou W, Shi Y, Cao W, Cao C. Percutaneous stenting for malignant hilar biliary obstruction: a randomized controlled trial of unilateral versus bilateral stenting. Abdom Radiol 2019;44:2900-8. [DOI: 10.1007/s00261-019-02010-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
65 Zhang X, Beal EW, Merath K, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Weiss M, Scoggins C, Martin RC, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival. J Surg Oncol 2018;117:1267-77. [DOI: 10.1002/jso.24945] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
66 Yang G, Xiong Y, Sun J, Tang T, Li W, Wang G, Li J. Effects of different preoperative biliary drainage methods for resected malignant obstruction jaundice on the incidence rate of implantation metastasis: A meta-analysis. Oncol Lett 2020;20:2217-24. [PMID: 32782538 DOI: 10.3892/ol.2020.11767] [Reference Citation Analysis]
67 Lu Y, Liu L, Wu J, Bie L, Gong B. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2015;39:718-24. [DOI: 10.1016/j.clinre.2014.10.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
68 Wang X, Hu J, Cao G, Zhu X, Cui Y, Ji X, Li X, Yang R, Chen H, Xu H, Liu P, Li J, Li J, Hao C, Xing B, Shen L. Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma. Radiology 2017;283:580-9. [PMID: 27820684 DOI: 10.1148/radiol.2016160572] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
69 Zheng WH, Yu T, Luo YH, Wang Y, Liu YF, Hua XD, Lin J, Ma ZH, Ai FL, Wang TL. Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma. World J Gastrointest Oncol 2019; 11(6): 489-498 [PMID: 31236199 DOI: 10.4251/wjgo.v11.i6.489] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Zhang T, Cai X, Li Q, Xue P, Chen Z, Dong X, Xue Y. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC). Oncotarget 2016;7:42225-40. [PMID: 27302926 DOI: 10.18632/oncotarget.9944] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
71 Matsubayashi H, Kishida Y, Imai K, Hotta K, Kakushima N, Tanaka M, Takizawa K, Ono H. Unilateral multiple metallic stent-in-stent for a case of hilar biliary cancer: an alternative stenting strategy. Saudi J Gastroenterol 2014;20:199-201. [PMID: 24976285 DOI: 10.4103/1319-3767.133035] [Reference Citation Analysis]
72 Peter S, Wilcox CM. Endoscopic "crossroads" in the management of malignant hilar strictures. Indian J Gastroenterol 2013;32:363-5. [PMID: 24158899 DOI: 10.1007/s12664-013-0418-y] [Reference Citation Analysis]
73 Baillie J, Vachhani R. Y-Shaped, Self-Expanding Metallic Stents (SEMS) to Drain Malignant Strictures of the Liver Hilum: Y Are They Better? Dig Dis Sci 2017;62:10-2. [PMID: 27853899 DOI: 10.1007/s10620-016-4350-8] [Reference Citation Analysis]
74 Hsieh J, Thosani A, Grunwald M, Nagula S, Bucobo JC, Buscaglia JM. Serial insertion of bilateral uncovered metal stents for malignant hilar obstruction using an 8 Fr biliary system: a case series of 17 consecutive patients. Hepatobiliary Surg Nutr 2015;4:348-53. [PMID: 26605283 DOI: 10.3978/j.issn.2304-3881.2015.06.03] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
75 Ku D, Tang R, Pang T, Pleass H, Richardson A, Yuen L, Lam V. Survival outcomes of hepatic resections in Bismuth-Corlette type IV cholangiocarcinoma. ANZ J Surg 2020;90:1604-14. [PMID: 31840387 DOI: 10.1111/ans.15531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
76 Sun CC, Li SJ, Li G, Hua RX, Zhou XH, Li DJ. Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57. Mol Ther Nucleic Acids 2016;5:e385. [PMID: 27845772 DOI: 10.1038/mtna.2016.94] [Cited by in Crossref: 135] [Cited by in F6Publishing: 146] [Article Influence: 22.5] [Reference Citation Analysis]
77 Baron TH. Endoscopic management of biliary disorders: diagnostic and therapeutic. Surg Clin North Am. 2014;94:395-411. [PMID: 24679428 DOI: 10.1016/j.suc.2013.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
78 Ke SB, Qiu H, Chen JM, Shi W, Chen YS. MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1. Gene 2018;676:329-35. [PMID: 30144500 DOI: 10.1016/j.gene.2018.08.064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
79 Pranculis A, Kievišas M, Kievišienė L, Vaičius A, Vanagas T, Kaupas RS, Dambrauskas Ž. Percutaneous Transhepatic Biliary Stenting with Uncovered Self-Expandable Metallic Stents in Patients with Malignant Biliary Obstruction - Efficacy and Survival Analysis. Pol J Radiol 2017;82:431-40. [PMID: 29662569 DOI: 10.12659/PJR.901785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
80 Xia MX, Pan YL, Cai XB, Wu J, Gao DJ, Ye X, Wang TT, Hu B. Comparison of endoscopic bilateral metal stent drainage with plastic stents in the palliation of unresectable hilar biliary malignant strictures: Large multicenter study. Dig Endosc 2021;33:179-89. [PMID: 32249460 DOI: 10.1111/den.13680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
81 Li CX, Zhang H, Wang K, Wang X, Li XC. Preoperative Bilirubin Level Predicts Overall Survival and Tumor Recurrence After Resection for Perihilar Cholangiocarcinoma Patients. Cancer Manag Res 2019;11:10157-65. [PMID: 31819648 DOI: 10.2147/CMAR.S230620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Al-Kawas F, Aslanian H, Baillie J, Banovac F, Buscaglia JM, Buxbaum J, Chak A, Chong B, Coté GA, Draganov PV, Dua K, Durkalski V, Elmunzer BJ, Foster LD, Gardner TB, Geller BS, Jamidar P, Jamil LH, Keswani RN, Khashab MA, Lang GD, Law R, Lichtenstein D, Lo SK, McCarthy S, Melo S, Mullady D, Nieto J, Bayne Selby J, Singh VK, Spitzer RL, Strife B, Tarnaksy P, Taylor JR, Tokar J, Wang AY, Williams A, Willingham F, Yachimski P; In alphabetical order for the INTERCPT Study Group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE). Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial. Trials 2018;19:108. [PMID: 29444707 DOI: 10.1186/s13063-018-2473-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
83 Lee TH, Park DH. Endoscopic prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastroenterol 2014; 20(44): 16582-16595 [PMID: 25469026 DOI: 10.3748/wjg.v20.i44.16582] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
84 Yang XJ, Huang CQ, Peng CW, Hou JX, Liu JY. Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression. Gene. 2016;592:172-178. [PMID: 27496341 DOI: 10.1016/j.gene.2016.08.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
85 Goral V. Cholangiocarcinoma: New Insights. Asian Pac J Cancer Prev 2017;18:1469-73. [PMID: 28669153 DOI: 10.22034/APJCP.2017.18.6.1469] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
86 Gavriilidis P, Askari A, Roberts KJ, Sutcliffe RP. Appraisal of the current guidelines for management of cholangiocarcinoma-using the Appraisal of Guidelines Research and Evaluation II (AGREE II) Instrument. Hepatobiliary Surg Nutr 2020;9:126-35. [PMID: 32355672 DOI: 10.21037/hbsn.2019.09.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
87 Wang L, Lin N, Xin F, Ke Q, Zeng Y, Liu J. A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction. World J Surg Oncol 2019;17:116. [PMID: 31277666 DOI: 10.1186/s12957-019-1656-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
88 Caillol F, Bories E, Zemmour C, Pesenti C, Ratone JP, Gilabert M, Launay S, Giovannini M. Palliative endoscopic drainage of malignant stenosis of biliary confluence: Efficiency of multiple drainage approach to drain a maximum of liver segments. United European Gastroenterol J 2019;7:52-9. [PMID: 30788116 DOI: 10.1177/2050640618803812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
89 Fang J, Sun CC, Gong C. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression. Biochem Biophys Res Commun 2016;478:811-7. [PMID: 27501756 DOI: 10.1016/j.bbrc.2016.08.030] [Cited by in Crossref: 130] [Cited by in F6Publishing: 134] [Article Influence: 21.7] [Reference Citation Analysis]
90 Moole H, Dharmapuri S, Duvvuri A, Dharmapuri S, Boddireddy R, Moole V, Yedama P, Bondalapati N, Uppu A, Yerasi C. Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review. Can J Gastroenterol Hepatol 2016;2016:4726078. [PMID: 27648439 DOI: 10.1155/2016/4726078] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
91 Camacho JC, Brody LA, Covey AM. Treatment of Malignant Bile Duct Obstruction: What the Interventional Radiologist Needs to Know. Semin Intervent Radiol 2021;38:300-8. [PMID: 34393340 DOI: 10.1055/s-0041-1731269] [Reference Citation Analysis]
92 Li S, Li B, Li L, Yang X, Xu F, Wang W. The efficacy of the combination of percutaneous transhepatic biliary drainage and 125I stranded seeds for malignant bile duct obstruction treatment. J Contemp Brachytherapy 2020;12:225-32. [PMID: 32695193 DOI: 10.5114/jcb.2020.96862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Teng F, Tang YY, Dai JL, Li Y, Chen ZY. The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis. World J Surg Oncol 2020;18:174. [PMID: 32682432 DOI: 10.1186/s12957-020-01904-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Tan Y, Qiu BA, Xia NX, Yang YX, Zhu JY, Liu P, An Y, Wu YT. Liver transplantation for hilar cholangiocarcinoma: Analysis of 7 cases. Shijie Huaren Xiaohua Zazhi 2015; 23(2): 313-317 [DOI: 10.11569/wcjd.v23.i2.313] [Reference Citation Analysis]
95 Jo JH, Chung MJ, Han DH, Park JY, Bang S, Park SW, Song SY, Chung JB. Best options for preoperative biliary drainage in patients with Klatskin tumors. Surg Endosc. 2017;31:422-429. [PMID: 27287904 DOI: 10.1007/s00464-016-4993-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
96 De Moura DTH, Moura EGH, Bernardo WM, De Moura ETH, Baraca FI, Kondo A, Matuguma SE, Almeida Artifon EL. Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: Systematic review and meta-analysis. Endosc Ultrasound 2018;7:10-9. [PMID: 27824027 DOI: 10.4103/2303-9027.193597] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
97 Kongkam P, Orprayoon T, Boonmee C, Sodarat P, Seabmuangsai O, Wachiramatharuch C, Auan-Klin Y, Pham KC, Tasneem AA, Kerr SJ, Romano R, Jangsirikul S, Ridtitid W, Angsuwatcharakon P, Ratanachu-Ek T, Rerknimitr R. ERCP plus endoscopic ultrasound-guided biliary drainage versus percutaneous transhepatic biliary drainage for malignant hilar biliary obstruction: a multicenter observational open-label study. Endoscopy 2021;53:55-62. [PMID: 32515005 DOI: 10.1055/a-1195-8197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
98 Zhu HD, Guo JH, Huang M, Ji JS, Xu H, Lu J, Li HL, Wang WH, Li YL, Ni CF, Shi HB, Xiao EH, Lv WF, Sun JH, Xu K, Han GH, Du LA, Ren WX, Li MQ, Mao AW, Xiang H, Zhang KX, Min J, Zhu GY, Su C, Chen L, Teng GJ. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial. J Hepatol. 2018;68:970-977. [PMID: 29331343 DOI: 10.1016/j.jhep.2017.12.028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
99 Ogura T, Takenaka M, Shiomi H, Nishioka N, Ueno S, Miyano A, Kamiyama R, Higuchi K. Single-session multiple stent deployment using moving cell stent without dilating initial stent mesh to treat malignant hilar biliary obstruction (with videos). J Hepatobiliary Pancreat Sci 2020;27:84-9. [PMID: 31628892 DOI: 10.1002/jhbp.688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
100 Jiao D, Huang K, Zhu M, Wu G, Ren J, Wang Y, Han X. Placement of a Newly Designed Y-Configured Bilateral Self-Expanding Metallic Stent for Hilar Biliary Obstruction: A Pilot Study. Dig Dis Sci 2017;62:253-63. [PMID: 27586033 DOI: 10.1007/s10620-016-4284-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
101 Kawai J, Ogura T, Takenaka M, Shiomi H, Ueshima K, Ueno S, Okuda A, Matsuno J, Minaga K, Omoto S, Nakai A, Ikegawa T, Hakoda A, Higuchi K. Prospective multicenter evaluation of moving cell metallic stents in endoscopic multiple stent deployment for hepatic hilar obstruction. J Hepatobiliary Pancreat Sci 2021. [PMID: 34110699 DOI: 10.1002/jhbp.1009] [Reference Citation Analysis]
102 Ba Y, Yue P, Leung JW, Wang H, Lin Y, Bai B, Zhu X, Zhang L, Zhu K, Wang W, Meng W, Zhou W, Liu Y, Li X. Percutaneous transhepatic biliary drainage may be the preferred preoperative drainage method in hilar cholangiocarcinoma. Endosc Int Open 2020;8:E203-10. [PMID: 32010755 DOI: 10.1055/a-0990-9114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Jang SI, Lee DK. Update on Pancreatobiliary Stents: Stent Placement in Advanced Hilar Tumors. Clin Endosc 2015;48:201-8. [PMID: 26064819 DOI: 10.5946/ce.2015.48.3.201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
104 Ashat M, Arora S, Klair JS, Childs CA, Murali AR, Johlin FC. Bilateral vs unilateral placement of metal stents for inoperable high-grade hilar biliary strictures: A systemic review and meta-analysis. World J Gastroenterol 2019; 25(34): 5210-5219 [PMID: 31558868 DOI: 10.3748/wjg.v25.i34.5210] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
105 Zhang JX, Liu J, Wang B, Liu S, Zu QQ, Shi HB. Retrospective comparison of different percutaneous approaches to manage occluded primary uncovered self-expandable metal stents in patients with unresectable malignant hilar biliary obstruction. Scand J Gastroenterol 2019;54:1397-402. [PMID: 31656114 DOI: 10.1080/00365521.2019.1683602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Kimbrough CW, Cloyd JM, Pawlik TM. Surgical approaches for the treatment of perihilar cholangiocarcinoma. Expert Review of Anticancer Therapy 2018;18:673-83. [DOI: 10.1080/14737140.2018.1473039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
107 Winkler J, Caillol F, Ratone JP, Bories E, Pesenti C, Giovannini M. Feasibility of EUS-guided hepaticogastrostomy for inoperable malignant hilar biliary strictures. Endosc Ultrasound 2021;10:51-6. [PMID: 33402550 DOI: 10.4103/eus.eus_68_20] [Reference Citation Analysis]
108 Elmunzer BJ, Smith ZL, Tarnasky P, Wang AY, Yachimski P, Banovac F, Buscaglia JM, Buxbaum J, Chak A, Chong B, Coté GA, Draganov PV, Dua K, Durkalski V, Geller BS, Jamil LH, Keswani RN, Khashab MA, Law R, Lo SK, McCarthy S, Selby JB, Singh VK, Taylor JR, Willingham FF, Spitzer RL, Foster LD; INTERCPT study group and the United States Cooperative for Outcomes Research in Endoscopy (USCORE). An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction. Clin Gastroenterol Hepatol 2021;19:1282-4. [PMID: 32454259 DOI: 10.1016/j.cgh.2020.05.035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Miura S, Kanno A, Masamune A, Hamada S, Takikawa T, Nakano E, Yoshida N, Hongo S, Kikuta K, Kume K. Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture. Surg Endosc. 2015;29:1862-1870. [PMID: 25277483 DOI: 10.1007/s00464-014-3878-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
110 Inoue T, Naitoh I, Okumura F, Ozeki T, Anbe K, Iwasaki H, Nishie H, Mizushima T, Sano H, Nakazawa T, Yoneda M, Joh T. Reintervention for stent occlusion after bilateral self-expandable metallic stent placement for malignant hilar biliary obstruction: Reintervention for hilar RBO. Digestive Endoscopy 2016;28:731-7. [DOI: 10.1111/den.12657] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
111 Cannavale A, Santoni M, Gazzetti M, Maher B, Fanelli F, Fiocca F, Catalano C. Updated Management of Malignant Biliary Tract Tumors: An Illustrative Review. Journal of Vascular and Interventional Radiology 2016;27:1056-69. [DOI: 10.1016/j.jvir.2016.01.149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Joo I, Lee JM, Yoon JH. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology 2018;288:7-13. [DOI: 10.1148/radiol.2018171187] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
113 Moon JH, Rerknimitr R, Kogure H, Nakai Y, Isayama H. Topic controversies in the endoscopic management of malignant hilar strictures using metal stent: side-by-side versus stent-in-stent techniques. J Hepatobiliary Pancreat Sci. 2015;22:650-656. [PMID: 26136361 DOI: 10.1002/jhbp.270] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
114 Shah KN, Clary BM. Endoscopic and Percutaneous Approaches to the Treatment of Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 2014;23:207-30. [DOI: 10.1016/j.soc.2013.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
115 Fukasawa M, Takano S, Shindo H, Takahashi E, Sato T, Enomoto N. Endoscopic biliary stenting for unresectable malignant hilar obstruction. Clin J Gastroenterol 2017;10:485-90. [PMID: 29052124 DOI: 10.1007/s12328-017-0778-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
116 Li X, Li J, Ou YJ, Zhu XX, Yin XY, Zhu YX, Tang D. Hepatoprotective effect of ulinastatin in a rat model of major hepatectomy after obstructive jaundice. Dig Dis Sci 2015;60:1680-9. [PMID: 25647759 DOI: 10.1007/s10620-015-3543-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
117 Corvino F, Centore L, Soreca E, Corvino A, Farbo V, Bencivenga A. Percutaneous "Y" biliary stent placement in palliative treatment of type 4 malignant hilar stricture. J Gastrointest Oncol 2016;7:255-61. [PMID: 27034794 DOI: 10.3978/j.issn.2078-6891.2015.069] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
118 Perez-Johnston R, Deipolyi AR, Covey AM. Percutaneous Biliary Interventions. Gastroenterol Clin North Am 2018;47:621-41. [PMID: 30115441 DOI: 10.1016/j.gtc.2018.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
119 Zhou T, Liu L, Dai HS, Zhang CC, He Y, Zhang LD, Li DJ, Bie P, Ding J, Chen ZY; other members of the Hilar Cholangiocarcinoma Study Group. Impact of body mass index on postoperative outcomes in patients undergoing radical resection for hilar cholangiocarcinoma. J Surg Oncol 2020;122:1418-25. [PMID: 32794267 DOI: 10.1002/jso.26172] [Reference Citation Analysis]
120 Li M, Li K, Qi X, Wu W, Zheng L, He C, Yin Z, Fan D, Zhang Z, Han G. Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients. Journal of Vascular and Interventional Radiology 2016;27:1047-1055.e2. [DOI: 10.1016/j.jvir.2016.02.035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
121 Lee TH, Moon JH, Park SH. Bilateral metallic stenting in malignant hilar obstruction. Clin Endosc. 2014;47:440-446. [PMID: 25325005 DOI: 10.5946/ce.2014.47.5.440] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]